Delhi conducted its fifth sero-prevalence survey in January and the results have revealed that the National Capital is inching closer towards attaining herd immunity against COVID-19.
The latest sero-survey has found that every second person in Delhi has developed antibodies against the novel coronavirus. Meaning, out of the over two-crore people residing in Delhi, nearly one crore people have already contracted COVID-19 and recovered from it.
What is a sero-survey and will it help in the fight against COVID-19?
Though the Delhi government is yet to announce the result of the survey, a source privy to it has revealed: “In one district, the sero-prevalence rate is between 50-60 percent, indicating a large number of people have developed antibodies, so we can say the city is moving towards attaining herd immunity.”
A population is deemed to have attained herd immunity if 50 to 60 percent of the people are found to have developed antibodies during a sero-prevalence survey.
Notably, this was the fifth sero-survey conducted in Delhi; it was kicked off on January 11 and 28,000 samples were collected during the exercise.6.6% Indians aged above 10 were exposed to COVID-19 by August: Sero-survey
The first one was done in July 2020 and had revealed that 23 percent of the surveyed population had developed antibodies against COVID-19.
The previous serological survey conducted in Delhi in October had revealed that 25.5 percent of the population had COVID-19 antibodies. The September survey had shown sero-prevalence in 25.1 percent of the population, while the August survey had found antibodies in 29.1 percent of Delhi’s population.
With PTI inputs
Follow our coverage of the coronavirus crisis here
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.